©istock.com/Andrea Obzerova
Interdisciplinary CompetenceMolecular Diagnostics
Know how in the analysis of genetic material.
For the benefit of patients.

IllnessCataract, syndromal; differential diagnosis

Summary

Short information

A curated panel containing 123 genes for the comprehensive analysis of practically all known genetic and syndromic cataract entities

ID
KP0010
Number of genes
121 Accredited laboratory test
Examined sequence length
0,0 kb (Core-/Core-canditate-Genes)
268,1 kb (Extended panel: incl. additional genes)
Analysis Duration
on request
Test material
  • EDTA-anticoagulated blood (3-5 ml)
Diagnostic indications

NGS +

[Sanger]

 

Gene panel

Selected genes

NameExon Length (bp)OMIM-GReferenz-Seq.Heredity
ABHD121197NM_001042472.3AR
ADAMTS103312NM_030957.4AR
AGK1269NM_018238.4AR
AGPS1977NM_003659.4AR
ALDH18A12388NM_002860.4AD, AR
ANAPC15835NM_022662.4AR
ATAD3A1761NM_001170535.3AR
B3GLCT1497NM_194318.4AR
BCOR5166NM_017745.6XL
CDK91126NM_001261.4AR
COG42295NM_001195139.2AR
COL11A15421NM_001854.4AD, AR
COL18A14560NM_001379500.1AR
COL2A14464NM_001844.5AD
COL4A15010NM_001845.6AD, Mult
COL4A55058NM_000495.5XL
COPB12883NM_001144061.2AR
CRYAA522NM_000394.4AD, AR
CRYAB528NM_001885.3AD, AR
CRYBA4591NM_001886.3AD
CRYBB1759NM_001887.4AD, AR
CRYBB2618NM_000496.3AD
CRYBB3636NM_004076.5AD, AR
CRYGC525NM_020989.4AD
CTDP12529NM_004715.5AR
CYP27A11596NM_000784.4AR
CYP51A11540NM_000786.4XL
DHCR71428NM_001360.3AR
DMPK1920NM_001081563.2AD
DNMBP6032NM_015221.4AD
DYRK1A2292NM_001396.5AD
EED2100NM_003797.5AD
EIF2B21056NM_014239.4AD
EPG57740NM_020964.3AR
EPHA22931NM_004431.5AD
ERCC22283NM_000400.4AR
ERCC32349NM_000122.2AR
ERCC64482NM_000124.4AR
ERCC81191NM_000082.4AR
EYA11779NM_000503.6AD
FAR11548NM_032228.6AR, AD
FBN18616NM_000138.5AD
FOXC11662NM_001453.3AD
FOXE3960NM_012186.3AD, AR
FTL528NM_000146.4AD
GALK11179NM_000154.2AR
GALM1069NM_138801.3AR
GALT1140NM_000155.4AR
GCNT21203NM_001491.3n.k.
GEMIN43177NM_015721.3AR
GFER618NM_005262.3AR
GLS1797NM_001256310.2AD
GNPAT2043NM_014236.4AR
GTF2H5216NM_207118.3AR
HMX11047NM_018942.3AR
HTRA21377NM_013247.5AR
HYCC11566NM_032581.4AR
INPP5K1119NM_016532.4AR
INTS16843NM_001080453.3AR
JAM3780NM_001205329.2AR
LCAT1323NM_000229.2AR
LIM2648NM_030657.4AR
LONP12688NM_001276479.2AR
LSS2303NM_001001438.3AR
MAF1212NM_005360.5AD
MAN2B13036NM_000528.4AR
MED271160NM_001253881.2AR
MSMO1489NM_001017369.3AR
MYH95883NM_002473.6AD
NACC11589NM_052876.4AD
NDP402NM_000266.4XLR
NF21788NM_000268.4AD
NHS4425NM_001136024.4XL
NUP1885294NM_015354.3AD
OCRL2706NM_000276.4XLR
OPA3540NM_025136.4AD
P3H21584NM_001134418.2AR
PAX61269NM_000280.5AD
PEX13852NM_000466.3AR
PEX101041NM_153818.2AR
PEX11B780NM_003846.3AR
PEX121080NM_000286.3AR
PEX131212NM_002618.4AR
PEX141134NM_004565.3AR
PEX161011NM_004813.4AR
PEX19900NM_002857.4AR
PEX2918NM_000318.3AR
PEX26918NM_017929.6AR
PEX31122NM_003630.3AR
PEX51920NM_001131025.2AR
PEX62943NM_000287.4AR
PEX7972NM_000288.4AR
PGRMC1588NM_006667.5AD
PIK3C2A5093NM_002645.4AR
PITX3909NM_005029.4AD
PLOD32217NM_001084.5AR
POLG3720NM_002693.3AD, AR
POMT12244NM_007171.4AR
PSMC31501NM_002804.5AD
PXDN4440NM_012293.3AR
RAB18621NM_021252.5AR
RAB3GAP12946NM_012233.3AR
RAB3GAP24182NM_012414.4AR
RECQL43628NM_004260.4AR
RIC13498NM_001135920.4AD
SEC23A2298NM_006364.4AR
SIL11386NM_022464.5AR
SLC16A121551NM_213606.4AD
SLC2A11479
  • No OMIM-Gs linked
NM_006516.4AD
SLC33A11650NM_004733.4AR
SMG82988NM_018149.7AR
SRD5A3957NM_024592.5AR
SREBF13534NM_001005291.3AD, AR
TBC1D201212NM_144628.4AR
TKFC2102NM_015533.4AR
VPS4A1325NM_013245.3AD
VSX21086NM_182894.3AR
WFS12673NM_006005.3AD, AR
WRN4299NM_000553.6AR
XYLT22598NM_022167.4AR
ZNF5262013NM_133444.3AR

Informations about the disease

Clinical Comment

Heterogenous disorders

 

Synonyms
  • Alias: Cataract, syndromal
  • Allelic: Adult i phenotype without cataract (GCNT2)
  • Allelic: Blood group, Ii (GCNT2)
  • Allelic: Cardiomyopathy, dilated, 1II (CRYAB)
  • Allelic: Cataract 38, AR (AGK)
  • Allelic: Deafness, autosomal dominant 37 (COL11A1)
  • Allelic: Dent disease 2 (OCRL)
  • Allelic: Epilepsy, idiopathic generalized, susceptibility to, 12 (SLC2A1)
  • Allelic: Fibrochondrogenesis 1 (COL11A1)
  • Allelic: Lumbar disc herniation, susceptibility to (COL11A1)
  • Allelic: Myopathy, myofibrillar, 2 (CRYAB)
  • Allelic: Premature ovarian insufficiency [panelapp] (PGRMC1)
  • Allelic: Spastic paraplegia 9A, AD (ALDH18A1)
  • Allelic: Spastic paraplegia 9B, AR (ALDH18A1)
  • Allelic: Stickler sydrome, type I, nonsyndromic ocular (COL2A1)
  • Allelic: Stickler syndrome, type II (COL11A1)
  • Allelic: Trichothiodystrophy 1, photosensitive (ERCC2)
  • Allelic: Vitreoretinopathy with phalangeal epiphyseal dysplasia (COL2A1)
  • Allelic: Xeroderma pigmentosum, group D (ERCC2)
  • Lysyl hydroxylase 3 deficiency (PLOD3)
  • 3-methylglutaconic aciduria, type VII, with cataracts, neurologic involvement, neutropenia (CLPB)
  • 3-methylglutaconic aciduria, type VIII (HTRA2)
  • AR cataract due to abnormal sterol metabolism [panelapp] (CYP51A1)
  • Acromicric dysplasia (FBN1)
  • Allelic: Pontocereb. hypoplasia, hypotonia, respiratory insufficiency s., neonatal lethal (ATAD3)
  • Alopecia-mental retardation syndrome 4 (LSS)
  • Alport syndrome 1, XL (COL4A5)
  • Alport syndrome 1, XL (COL4A5)
  • Alzahrani-Kuwahara syndrome: global developmental delay ID, poor/absent speech (SMG8)
  • Anterior segment anomalies with/-out cataract (EYA1)
  • Anterior segment dysgenesis 1, multiple subtypes (PITX)
  • Anterior segment dysgenesis 2, multiple subtypes (FOXE3)
  • Anterior segment dysgenesis 3, multiple subtypes (FOXC1)
  • Anterior segment dysgenesis 5, multiple subtypes (PAX6)
  • Anterior segment dysgenesis 7, with sclerocornea (PXDN)
  • Axenfeld-Rieger syndrome, type 3 (FOXC1)
  • Ayme-Gripp syndrome (MAF)
  • Baralle-Macken syndrome: neurodevelopmental disorder, cataracts, var. microcephaly (COPB1)
  • Brain small vessel disease with/-out ocular anomalies (COL4A1)
  • Branchiooculofacial syndrome (TFAP2A)
  • Branchiootorenal syndrome 1, with/-out cataracts (EYA1)
  • CATIFA syndrome: cleft lip, cataract, tooth abnormality, ID, face dysmorph, ADHS (RIC1)
  • CIMDAG syndr.: cereb. hypoplasia, cataract, ID, microceph., dystonia, anemia, red. growth (VPS4A)
  • CODAS [cerebral, ocular, dental, auricular + skeletal anomalies] syndrome (LONP1)
  • Cataract 1, multiple types (GJA8)
  • Cataract 11, multiple types (PITX)
  • Cataract 11, syndromic, AR (PITX)
  • Cataract 13 with adult i phenotype (GCNT2)
  • Cataract 14, multiple types (GJA3)
  • Cataract 15, multiple types (MIP)
  • Cataract 16, multiple types (CRYAB)
  • Cataract 17, multiple types (CRYBB1)
  • Cataract 19 (LIM2)
  • Cataract 2, multiple types (CRYGC)
  • Cataract 21, multiple types (MAF)
  • Cataract 22 (CRYBB3)
  • Cataract 23 (CRYBA4)
  • Cataract 3, multiple types (CRYBB2)
  • Cataract 34, multiple types (FOXE3)
  • Cataract 40, X-linked (NHS)
  • Cataract 41 (WFS1)
  • Cataract 44 (LSS)
  • Cataract 47, juvenile, with microcornea (SLC16A12)
  • Cataract 48 (DNMBP1)
  • Cataract 6, multiple types (EPHA2)
  • Cataract 9, multiple types (CRYAA)
  • Cataract with late-onset corneal dystrophy (PAX6)
  • Cerebrooculofacioskeletal syndrome 2 (ERCC2)
  • Cerebrotendinous xanthomatosis (CYP27A1)
  • Cohen-Gibson syndrome (EED)
  • Congenital cataracts, facial dysmorphism, neuropathy (CTDP1)
  • Congenital cataracts, hearing loss + neurodegeneration (SLC33A1)
  • Congenital disorder of glycosylation, type IIj (COG4)
  • Craniolenticulosutural dysplasia (SEC23A)
  • Cutis laxa, AD (ALDH18A1)
  • Cutis laxa, AR, type IIIA (ALDH18A1)
  • Dentici-Novelli neurodevelopmental syndrome (ZNF526)
  • Developmental + epileptic encephalopathy 71 (GLS
  • Dystonia 9 (SLC2A1)
  • Ectopia lentis, familial (FBN1)
  • Exudative vitreoretinopathy 2, XL (NDP)
  • Fish-eye disease (LCAT)
  • GLUT1 deficiency syndrome 1, infantile onset, severe (SLC2A1)
  • GLUT1 deficiency syndrome 2, childhood onset (SLC2A1)
  • Galactokinase deficiency with cataracts (GALK1)
  • Galactosemia (GALT)
  • Galactosemia IV (GALM)
  • Geleophysic dysplasia 2 (FBN1)
  • Glaucoma, primary closed-angle (COL18A1)
  • Global developmental delay, progressive ataxia + elevated glutamine (GLS)
  • Harel-Yoon syndrome (ATAD3)
  • Hemorrhagic destruction of the brain, subependymal calcification, and cataracts (JAM3)
  • Hyperferritinemia-cataract syndrome (FTL)
  • Hypotrichosis 14 (LSS)
  • ID, cataract; iris, ear, heart, skeletal + choanal morph., AKUT, seizures [panelapp] (CDK9)
  • Ichthyosis, follicular, with atrichia + photophobia syndrome 2 (SREBF1)
  • Infantile cataract, skin abnormalities, glutamate excess, impaired intellectual development (GLS)
  • Intellectual developmental disorder, AD 7 (DYRK1A)
  • Isolated paediatric cataract; Cataract [MONDO:0005129] [panelapp] (PGRMC1)
  • Kahrizi syndrome: mental retardation, cataracts, coloboma, kyphosis, coarse face (SRD5A3)
  • Knobloch syndrome, type 1 (COL18A1)
  • Lathosterolosis (SC5D)
  • Leukodystrophy, hypomyelinating, 5 (FAM126A)
  • Leukoencephalopathy with vanishing white matter (EIF2B2)
  • Lowe syndrome (OCRL)
  • MASS syndrome (FBN1)
  • Macrothrombocytopenia, granulocyte inclusions with/-out nephritis, sensorineural hearing loss (MYH9)
  • Mannosidosis, alpha-, types I, II (MAN2B1)
  • Marfan lipodystrophy syndrome (FBN1)
  • Marfan syndrome (FBN1)
  • Marinesco-Sjogren syndrome (SIL1)
  • Marshall syndrome (COL11A1)
  • Martsolf syndrome (RAB3GAP2)
  • Microcephaly, congenital cataract, psoriasiform dermatitis (MSMO1)
  • Microphthalmia with coloboma 3 (VSX2)
  • Microphthalmia, syndromic 2 (BCOR)
  • Mitochondrial DNA depletion syndrome 4B, Alpers + MNGIE types (POLG)
  • Mitochondrial recessive ataxia syndrome, includes SANDO + SCAE (POLG)
  • Mucoepithelial dysplasia, hereditary (SREBF1)
  • Muscular dystrophy, congenital, cataracts + intellectual disability (INPP5K)
  • Muscular dystrophy-dystroglycanopathy, cong. with ID, type B, 1 (POMT1)
  • Muscular dystrophy-dystroglycanopathy, cong. with brain + eye anomalies, type A, 1 (POMT1)
  • Muscular dystrophy-dystroglycanopathy, cong. with mental retardation, type B, 1 (POMT1)
  • Muscular dystrophy-dystroglycanopathy, limb-girdle, type C, 1 (POMT1)
  • Myopathy, mitochondrial progressive, congenital cataract, developmental delay (GFER)
  • Myopia, high, cataract + vitreoretinal degeneration (P3H2)
  • Myotonic dystrophy 1 (DMPK)
  • Nance-Horan syndrome: cong. cataract, dental anomalies, dysmorphic features, in some cases ID (NHS)
  • Neurodevelopmental disorder with cataracts, poor growth, dysmorphic facies (INTS1)
  • Neurodevelopmental disorder with microcephaly, cataracts + renal abnormalities (GEMIN4)
  • Neurodevelopmental disorder with spasticity, cataracts, cerebellar hypoplasia (MED27)
  • Neurodevelopmental disorder, epilepsy, cataracts, feeding diff., delayed brain myelin. (NACC1)
  • Neurofibromatosis, type 2 (NF2)
  • Norrie disease (NDP)
  • Norum disease (LCAT)
  • Oculoauricular syndrome (HMX1)
  • Oculoskeletodental syndrome (PIK3C2A)
  • Optic atrophy 3 with cataract (OPA3)
  • Ovarioleukodystrophy (EIF2B2)
  • Peroxisomal fatty acyl-CoA reductase 1 disorder (FAR1)
  • Peroxisome biogenesis disorders (PEX...)
  • Peters-plus syndrome (B3GLCT)
  • Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract (ABHD12)
  • Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, cataract (ADAMTS10)
  • Progressive external ophthalmoplegia, AD 1 (POLG)
  • Progressive external ophthalmoplegia, AR 1 (POLG)
  • Rhizomelic chondrodysplasia punctata, type 2 (GNPAT)
  • Rhizomelic chondrodysplasia punctata, type 3 (AGPS)
  • Rothmund-Thomson syndrome, type 1 (ANAPC1)
  • Rothmund-Thomson syndrome, type 2 (RECQL4)
  • Sandestig-Stefanova s.: micro-, trigonoceph., cataract, microphth., face, camptodactyly... (NUP188)
  • Saul-Wilson syndrome (COG4)
  • Sengers syndrome (AGK)
  • Smith-Lemli-Opitz syndrome (DHCR7)
  • Sorbitol dehydrogenase deficiency with peripheral neuropathy (SORD)
  • Spondyloocular syndrome (XYLT2)
  • Stickler syndrome, type I (COL2A1)
  • Stiff skin syndrome (FBN1)
  • Stomatin-deficient cryohydrocytosis with neurologic defects (SLC2A1)
  • Trichothiodystrophy 3, photosensitive (GTF2H5)
  • Triokinase + FMN cyclase deficiency syndrome (TKFC)
  • Vici syndrome (EPG5)
  • Warburg micro syndrome 1 (RAB3GAP1)
  • Warburg micro syndrome 2 (RAB3GAP2)
  • Warburg micro syndrome 3 (RAB18)
  • Warburg micro syndrome 4 (TBC1D20)
  • Weill-Marchesani syndrome 2, AD (FBN1)
  • Weill-Marchesani syndrome 2, dominant (FBN1)
  • Werner syndrome (WRN)
Heredity, heredity patterns etc.
  • AD
  • AR
  • Mult
  • XL
  • XLR
  • n.k.
OMIM-Ps
  • Multiple OMIM-Ps
ICD10 Code

Bioinformatics and clinical interpretation

Test-Stärken

  • DAkkS-akkreditiertes Labor
  • EU-Richtlinie für IVD in Umsetzung
  • Qualitäts-kontrolliert arbeitendes Personal
  • Leistungsstarke Sequenzierungstechnologien, fortschrittliche Target-Anreicherungsmethoden und Präzisions-Bioinformatik-Pipelines sorgen für überragende analytische Leistung
  • Sorgfältige Kuratierung klinisch relevanter und wissenschaftlich begründeter Gen-Panels
  • eine Vielzahl nicht Protein-kodierender Varianten, die in unseren klinischen NGS-Tests mit erfasst werden
  • unser strenges Variantenklassifizierungsschema nach ACMG-Kriterien
  • unser systematischer klinischer Interpretations-Workflow mit proprietärer Software ermöglicht die genaue und nachvollziehbare Verarbeitung von NGS-Daten
  • unsere umfassenden klinischen Aussagen

Testeinschränkungen

  • Gene mit eingeschränkter Abdeckung werden gekennzeichnet
  • Gene mit kompletten oder partiellen Duplikationen werden gekennzeichnet
  • es wird angenommen, dass ein Gen suboptimal abgedeckt ist, wenn >90% der Nukleotide des Gens bei einem Mapping-Qualitätsfaktor von >20 (MQ>20) nicht abgedeckt sind
  • die Sensitivität der Diagnostik zur Erkennung von Varianten mit genannten Testeinschränkungen ist möglicherweise begrenzt bei:
  • Gen-Konversionen
  • komplexe Inversionen
  • Balancierte Translokationen
  • Mitochondriale Varianten
  • Repeat-Expansionen, sofern nicht anders dokumentiert
  • nicht kodierende Varianten, die Krankheiten verursachen, die von diesem Panel nicht mit abgedeckt werden
  • niedriger Mosaik-Status
  • Repeat-Blöcke von Mononukleotiden
  • Indels >50bp (Insertionen-Deletionen)
  • Deletionen oder Duplikationen einzelner Exons
  • Varianten innerhalb von Pseudogenen
  • die analytische Sensitivität kann geringer ausfallen werden, wenn die DNA nicht von amedes genetics extrahiert wurde

Laboratory requirement

  • Die in grün gezeigten Gene sind kuratiert und werden als Gen-Panel untersucht. Eine Erweiterung des Panels (blau gezeigte Gene, jeweils ebenfalls kuratiert) kann auf Anfrage erfolgen. Sofern unter "Erweitertes Panel" ein Minuszeichen angezeigt wird, sind nur Core-/Basis-Gene verfügbar.

  • Für die Anforderung einer genetischen Untersuchung senden Sie uns bitte die Krankheits-ID auf einem Überweisungsschein. Bitte die Material-Angabe beachten.

  • Für privat versicherte Patienten empfehlen wir einen Antrag auf Kostenübernahme bei der Krankenversicherung.

  • Die Untersuchung wird auch für Selbstzahler angeboten.